Among important regulatory news last week, US drugmaker BridgeBio Pharma gained Food and Drug Administration (FDA) approval ...

Belgium’s largest drugmaker UCB on Friday announced the successful closing of the sale, divestment and license of its mature ...

Kelun-Biotech has received marketing authorization in China for sacituzumab tirumotecan (sac-TMT), a Trop2-directed ADC for ...

AI-powered protein engineering company Cradle has raised $73 million in a Series B funding. The European firm, which has now ...

Allink Biotherapeutics, a Chinese startup specializing in bispecific antibodies and antibody-drug conjugates, raises $42 ...

AstraZeneca and Daiichi Sankyo’s breast cancer drug Enhertu to join China’s state health insurance in 2025, enhancing ...

Minghui Pharmaceutical announces successful Phase III trial of MH004 for atopic dermatitis, achieving significant skin ...

The Danish Ministry of Interior and Health has announced that the political parties have decided to permanently legalize ...

During the Belgian Economic Mission to Brazil, a historic Memorandum of Understanding (MoU) was signed between the Brazilian ...

Evotec's COO Craig Johnstone will leave by year-end as the company implements its Priority Reset restructuring amid declining ...

Galderma announces successful Phase III trial results for Nemluvio in treating prurigo nodularis, driving record trading ...

Indian drugmaker Dr Reddy’s Laboratories has launched its toripalimab in the domestic market, sending the firm’s share up 2%.